MHRA Updates List of New Manufacturing and Wholesale Dealer Licences for May 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has published an updated list of sites granted new manufacturing and wholesale dealer licences for medicines in the United Kingdom. This official announcement, dated May 7, 2026, serves as the latest monthly update to a continuous record of regulatory approvals. The document provides a comprehensive overview of all new licences issued over the previous year, ensuring transparency in the pharmaceutical supply chain. The data is available in a CSV format, allowing stakeholders to access detailed information regarding specific facilities authorized to manufacture or distribute medicinal products. This routine administrative update reflects the MHRA's ongoing commitment to regulating the safety and quality of medicines by monitoring licensed entities. The page history indicates consistent monthly updates since early 2021, highlighting the dynamic nature of the pharmaceutical licensing landscape. By maintaining this public register, the agency supports industry compliance and public trust in the regulatory framework governing healthcare products. The update specifically includes the file for May 2026, replacing previous versions to ensure current accuracy for manufacturers, wholesalers, and regulatory observers.
Wire timeline
MHRA Updates List of New Manufacturing and Wholesale Dealer Licences for May 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has published an updated list of sites granted new manufacturing and wholesale dealer licences for medicines in the United Kingdom. This official announcement, dated May 7, 2026, serves as the latest monthly update to a continuous record of regulatory approvals. The document provides a comprehensive overview of all new licences issued over the previous year, ensuring transparency in the pharmaceutical supply chain. The data is available in a CSV format, allowing stakeholders to access detailed information regarding specific facilities authorized to manufacture or distribute medicinal products. This routine administrative update reflects the MHRA's ongoing commitment to regulating the safety and quality of medicines by monitoring licensed entities. The page history indicates consistent monthly updates since early 2021, highlighting the dynamic nature of the pharmaceutical licensing landscape. By maintaining this public register, the agency supports industry compliance and public trust in the regulatory framework governing healthcare products. The update specifically includes the file for May 2026, replacing previous versions to ensure current accuracy for manufacturers, wholesalers, and regulatory observers.
Medicines and Healthcare products Regulatory Agency - Activity on GOV.UK